Ghahramani Almanghadim H, Karimi B, Valizadeh S, Ghaedi K
Noncoding RNA Res. 2024; 10:70-90.
PMID: 39315339
PMC: 11417496.
DOI: 10.1016/j.ncrna.2024.09.001.
Uttam V, Kapoor H, Rana M, Yadav R, Prakash H, Jain M
Cancer Inform. 2024; 23:11769351241276757.
PMID: 39282627
PMC: 11401149.
DOI: 10.1177/11769351241276757.
Arshi A, Mahmoudi E, Raeisi F, Dehghan Tezerjani M, Bahramian E, Ahmed Y
Front Immunol. 2024; 15:1446937.
PMID: 39257589
PMC: 11384988.
DOI: 10.3389/fimmu.2024.1446937.
Ye L, Tong X, Pan K, Shi X, Xu B, Yao X
Front Pharmacol. 2024; 15:1351929.
PMID: 38895621
PMC: 11185051.
DOI: 10.3389/fphar.2024.1351929.
Li X, Meng Y, Gu B
Oncol Lett. 2024; 27(6):269.
PMID: 38686356
PMC: 11057035.
DOI: 10.3892/ol.2024.14402.
Immune-related LncRNAs scores predicts chemotherapeutic responses and prognosis in cervical cancer patients.
Tian W, Tan S, Wang J, Shen P, Qin Q, Zi D
Discov Oncol. 2024; 15(1):119.
PMID: 38615287
PMC: 11016529.
DOI: 10.1007/s12672-024-00979-1.
EZH2-Myc Hallmark in Oncovirus/Cytomegalovirus Infections and Cytomegalovirus' Resemblance to Oncoviruses.
El Baba R, Herbein G
Cells. 2024; 13(6.
PMID: 38534385
PMC: 10970056.
DOI: 10.3390/cells13060541.
Construction and validation of a transient receptor potential-related long noncoding RNA signature for prognosis prediction in breast cancer patients.
Guo Q, Qiu P, Pan K, Chen J, Wang B, Lin J
Medicine (Baltimore). 2023; 102(46):e35978.
PMID: 37986367
PMC: 10659707.
DOI: 10.1097/MD.0000000000035978.
The construction of a prognostic model of cervical cancer based on four immune-related LncRNAs and an exploration of the correlations between the model and oxidative stress.
Lv X, Jia Y, Li J, Deng S, Yuan E
Front Pharmacol. 2023; 14:1234181.
PMID: 37808187
PMC: 10551162.
DOI: 10.3389/fphar.2023.1234181.
Construction of Immune Infiltration-Related LncRNA Signatures Based on Machine Learning for the Prognosis in Colon Cancer.
Liu Z, Petinrin O, Toseef M, Chen N, Wong K
Biochem Genet. 2023; 62(3):1925-1952.
PMID: 37792224
DOI: 10.1007/s10528-023-10516-4.
Comprehensive analysis of ICD-related lncRNAs in predicting risk stratification, clinical prognosis and immune response for breast cancer.
Wang Y, Yue T, He Q
Aging (Albany NY). 2023; 15(17):8833-8850.
PMID: 37695742
PMC: 10522379.
DOI: 10.18632/aging.205002.
The landscape of lncRNAs in gastric cancer: from molecular mechanisms to potential clinical applications.
Silva J, Teixeira E, Mourao R, Ferraz R, Moreira F, Assumpcao P
Front Pharmacol. 2023; 14:1237723.
PMID: 37670949
PMC: 10476871.
DOI: 10.3389/fphar.2023.1237723.
Exploring the regulatory role of lncRNA in cancer immunity.
Zhan D, Xian H
Front Oncol. 2023; 13:1191913.
PMID: 37637063
PMC: 10448763.
DOI: 10.3389/fonc.2023.1191913.
Machine Learning-derived Multi-omics Prognostic Signature of Pyroptosis-related lncRNA with Regard to ZKSCAN2-DT and Tumor Immune Infiltration in Colorectal Cancer.
Chen J, Jin D, Shao L, Wang L, Zhou L, Cai J
Comb Chem High Throughput Screen. 2023; 27(8):1161-1174.
PMID: 37612868
PMC: 11327744.
DOI: 10.2174/1386207326666230823104952.
Construction and validation of a cuproptosis-related five-lncRNA signature for predicting prognosis, immune response and drug sensitivity in breast cancer.
Li C, Zhang Y
BMC Med Genomics. 2023; 16(1):158.
PMID: 37422644
PMC: 10329336.
DOI: 10.1186/s12920-023-01590-z.
Comprehensive analysis of the role of immune-related PANoptosis lncRNA model in renal clear cell carcinoma based on RNA transcriptome and single-cell sequencing.
Liu W, Qu C, Wang X
Oncol Res. 2023; 31(4):543-567.
PMID: 37415739
PMC: 10319599.
DOI: 10.32604/or.2023.029563.
The current advances of lncRNAs in breast cancer immunobiology research.
Fonseca-Montano M, Vazquez-Santillan K, Hidalgo-Miranda A
Front Immunol. 2023; 14:1194300.
PMID: 37342324
PMC: 10277570.
DOI: 10.3389/fimmu.2023.1194300.
LINC00426 is a potential immune phenotype-related biomarker and an overall survival predictor in PAM50 luminal B breast cancer.
Fonseca-Montano M, Cisneros-Villanueva M, Coales I, Hidalgo-Miranda A
Front Genet. 2023; 14:1034569.
PMID: 37260772
PMC: 10228735.
DOI: 10.3389/fgene.2023.1034569.
Roles of non-coding RNAs in the metabolism and pathogenesis of bladder cancer.
Sanya D, Onesime D
Hum Cell. 2023; 36(4):1343-1372.
PMID: 37209205
DOI: 10.1007/s13577-023-00915-5.
Breast cancer prognosis and immunological characteristics are predicted using the m6A/m5C/m1A/m7G-related long noncoding RNA signature.
Zhang L, Liu C, Zhang X, Wang C, Liu D
Funct Integr Genomics. 2023; 23(2):117.
PMID: 37014493
DOI: 10.1007/s10142-023-01026-y.